UNIVERSAL HEALTH SERVICES INC UHS revenue by segment, product and geography
In its fiscal year ending 2025-12-31, UNIVERSAL HEALTH SERVICES INC reported revenue across 3 business segments; the largest, Acute Care Hospital Services, was $9.93B, 57.2% of the filed sum (+11.0% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Acute Care Hospital Services$9.93B57.2%+11.0% yoy
- Behavioral Health Services$7.43B42.8%+8.0% yoy
- All Other Segments$13.4M0.1%+27.1% yoy
Members sum to the consolidated $17.4B for this period.
- Managed Care$4.9B28.2%+9.0% yoy
- Medicaid$2.69B15.5%+19.3% yoy
- Managed Medicaid$2.48B14.3%+7.8% yoy
- Managed Medicare$2.08B12.0%+10.4% yoy
- Medicare$1.86B10.7%+11.2% yoy
- Other Patient Revenue And Adjustments Net$1.24B7.1%+11.5% yoy
- Other Non Patient Revenue$1.11B6.4%-9.3% yoy
- UK Revenue$1B5.8%+13.8% yoy
Members sum to the consolidated $17.4B for this period.
- Acute Care Hospital Services$2.61B58.1%+10.7% yoy
- Behavioral Health Services$1.88B41.9%+8.2% yoy
- All Other Segments$2.89M0.1%+1.8% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.